 Citybizlist |
Targacept CEO steps down, leaves board
Boston.com The departure comes as the company has slashed its work force to cut costs after ending development of an experimental depression drug and setbacks in tests of another drug to treat asthma and diabetes. Its shares are down more than 80 percent in the … Targacept's CEO stepping down in reshuffle Biopharma company Targacept says CEO resigns Don deBethizy resigns as Targacept CEO |
View full post on asthma – Google News